+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Review of pathogenesis and treatment of degenerative joint disease

Review of pathogenesis and treatment of degenerative joint disease

Equine Veterinary Journal. Supplement: 3-11

Treatment of degenerative joint disease (osteoarthritis) is discussed in relationship to pathogenesis of five clinical entities, defined to facilitate discussion:-1) occurring in high motion joints and associated with synovitis; 2) associated with low motion joints; 3) "non-progressive" articular cartilage erosion; 4) secondary to other identified problems (intra-articular fractures, ligamentous damage, wounds, septic arthritis, osteochondrosis); and 5) chondromalacia of the patella. In addition to direct damage to articular cartilage, synovitis and capsulitis and depletion of matrical glycosaminoglycans and proteoglycans play important roles. The natural healing response in damaged articular cartilage is inadequate. The principles of treatment are divided into: 1) prevention or treatment of primary causes. These include the effects of track surface, shoeing, and the appropriate resolution of intra-articular fractures, septic arthritis and osteochondritis dissecans. 2) treatment of active soft tissue disease contributing to articular cartilage degeneration, including rest, physical therapy, synovectomy and administration of anti-inflammatory drugs, sodium hyaluronate and polysulfated glycosaminoglycans. 3) attempts at treatment of articular cartilage loss or degeneration, including articular cartilage curettage, subchondral bone drilling, osteophyte removal, articular cartilage grafting and arthrodesis.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 047267576

Download citation: RISBibTeXText

PMID: 9079056

DOI: 10.1111/j.2042-3306.1988.tb04641.x

Related references

Critical review of research evaluating glucosamine-based nutraceuticals for treatment of joint pain and degenerative joint disease in horses. Proceedings Of The 4th European Equine Health And Nutrition Congress: Ingen University And Research Centre. Wageningen, Netherlands, 18-19 Il, . . 81-91, 2008

Efficacy of glucosamine, chondroitin, and methylsulfonylmethane for spinal degenerative joint disease and degenerative disc disease: a systematic review. Journal of the Canadian Chiropractic Association 55(1): 47-55, 2011

Treatment of degenerative joint disease of the horse a review and commentary. Veterinary Surgery 10(2): 80-89, 1981

Pathogenesis of degenerative joint disease in the human temporomandibular joint. Critical Reviews in Oral Biology and Medicine 6(3): 248-277, 1995

Pathogenesis of degenerative joint disease. Equine Veterinary Journal 19(1): 15-18, 1987

A review of surgical outcomes of the Lapidus procedure for treatment of hallux abductovalgus and degenerative joint disease of the first MCJ. Foot 18(4): 206-210, 2008

Pathogenesis of degenerative temporomandibular joint disease. Journal of Dental Research 72(ABSTR SPEC ISSUE): 344, 1993

Natural history of degenerative joint disease in small laboratory animals. I. Pathologic anatomy of degenerative joint disease in mice. Arch Pathol 62(2): 118-128, 1956

Degenerative joint disease. The treatment of canine degenerative joint disease. Journal of Small Animal Practice 12(2): 101-103, 1971

Pathogenesis and pathologic anatomy of degenerative knee joint disease. Przeglad Lekarski 53(3): 178-180, 1996

Degenerative joint disease in dogs. Part II. Characterization and pathogenesis. Zycie Weterynaryjne 80(4): 216-221, 2005

Degenerative joint disease of the acromioclavicular joint: a review. American Journal of Sports Medicine 41(11): 2684-2692, 2013

Pathogenesis of degenerative joint disease produced by in vivo freezing of rabbit articular cartilage. Clinical Orthopaedics and Related Research 1981(155): 259-268, 1981

Clinical comparative study of microcurrent electrical stimulation to mid-laser and placebo treatment in degenerative joint disease of the temporomandibular joint. Cranio 13(2): 116-120, 1995